• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在TEMβ-内酰胺酶突变体中,对β-内酰胺酶抑制剂蛋白的耐药性与对克拉维酸的耐药性并不平行。

Resistance to beta-lactamase inhibitor protein does not parallel resistance to clavulanic acid in TEM beta-lactamase mutants.

作者信息

Schroeder William A, Locke Troy R, Jensen Susan E

机构信息

Department of Biological Sciences, University of Alberta, Edmonton, Alberta T6G 2E9, Canada.

出版信息

Antimicrob Agents Chemother. 2002 Nov;46(11):3568-73. doi: 10.1128/AAC.46.11.3568-3573.2002.

DOI:10.1128/AAC.46.11.3568-3573.2002
PMID:12384366
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC128715/
Abstract

In order to compare patterns of resistance to inhibition by clavulanic acid with patterns of resistance to inhibition by a beta-lactamase inhibitor protein (BLIP), R164S, R244S, and R164S/R244S mutant forms of TEM beta-lactamase were prepared by site-directed mutagenesis. When kinetic parameters were determined for these mutant and wild-type forms of TEM, the single mutants showed properties that were similar to those in the literature but the double mutant showed properties that were very different. The R164S/R244S double mutant form of TEM retained its resistance to inhibition by clavulanic acid (characteristic of the R244S mutation) but lost all its ability to hydrolyze ceftazidime (characteristic of the R164S mutation). While these characteristics are contrary to those previously reported for an R164S/R244S double mutant, this discrepancy resulted from the use of a defective mutant in the earlier study. Both the single and double mutant forms of TEM remained highly sensitive when tested for inhibition by BLIP, showing only slightly increased resistance compared to that of the wild type; this pattern of resistance is quite different from the pattern of clavulanic acid resistance. The slight increases in resistance to inhibition by BLIP seen in the mutants may have been related to the fact that all of the mutations effected changes in the net charge on the TEM protein that could impede interactions with BLIP.

摘要

为了比较对克拉维酸抑制的耐药模式与对β-内酰胺酶抑制蛋白(BLIP)抑制的耐药模式,通过定点诱变制备了TEMβ-内酰胺酶的R164S、R244S和R164S/R244S突变形式。当测定这些TEM突变型和野生型的动力学参数时,单突变体表现出与文献中相似的特性,但双突变体表现出非常不同的特性。TEM的R164S/R244S双突变体形式保留了对克拉维酸抑制的耐药性(R244S突变的特征),但失去了所有水解头孢他啶的能力(R164S突变的特征)。虽然这些特征与先前报道的R164S/R244S双突变体的特征相反,但这种差异是由于早期研究中使用了有缺陷的突变体。当测试TEM的单突变体和双突变体形式对BLIP的抑制时,它们仍然高度敏感,与野生型相比仅显示出略有增加的耐药性;这种耐药模式与克拉维酸耐药模式有很大不同。在突变体中观察到的对BLIP抑制的耐药性略有增加可能与以下事实有关:所有突变都导致TEM蛋白净电荷发生变化,这可能会阻碍与BLIP的相互作用。

相似文献

1
Resistance to beta-lactamase inhibitor protein does not parallel resistance to clavulanic acid in TEM beta-lactamase mutants.在TEMβ-内酰胺酶突变体中,对β-内酰胺酶抑制剂蛋白的耐药性与对克拉维酸的耐药性并不平行。
Antimicrob Agents Chemother. 2002 Nov;46(11):3568-73. doi: 10.1128/AAC.46.11.3568-3573.2002.
2
Mutant TEM beta-lactamase producing resistance to ceftazidime, ampicillins, and beta-lactamase inhibitors.产生对头孢他啶、氨苄西林和β-内酰胺酶抑制剂耐药性的突变体TEMβ-内酰胺酶。
Antimicrob Agents Chemother. 2002 Mar;46(3):646-53. doi: 10.1128/AAC.46.3.646-653.2002.
3
Substitution of Met-69 by Ala or Gly in TEM-1 beta-lactamase confer an increased susceptibility to clavulanic acid and other inhibitors.在TEM-1β-内酰胺酶中,将第69位的甲硫氨酸替换为丙氨酸或甘氨酸会增加对克拉维酸和其他抑制剂的敏感性。
FEMS Microbiol Lett. 2002 May 21;211(1):13-6. doi: 10.1111/j.1574-6968.2002.tb11196.x.
4
Selection and characterization of beta-lactam-beta-lactamase inactivator-resistant mutants following PCR mutagenesis of the TEM-1 beta-lactamase gene.TEM-1β-内酰胺酶基因经PCR诱变后β-内酰胺-β-内酰胺酶灭活剂抗性突变体的筛选与鉴定
Antimicrob Agents Chemother. 1998 Jul;42(7):1542-8. doi: 10.1128/AAC.42.7.1542.
5
Overcoming resistance to beta-lactamase inhibitors: comparing sulbactam to novel inhibitors against clavulanate resistant SHV enzymes with substitutions at Ambler position 244.克服对β-内酰胺酶抑制剂的耐药性:将舒巴坦与针对具有安布勒244位取代的克拉维酸耐药SHV酶的新型抑制剂进行比较。
Biochemistry. 2007 Oct 9;46(40):11361-8. doi: 10.1021/bi700792a. Epub 2007 Sep 12.
6
Reversal of clavulanate resistance conferred by a Ser-244 mutant of TEM-1 beta-lactamase as a result of a second mutation (Arg to Ser at position 164) that enhances activity against ceftazidime.TEM-1 β-内酰胺酶的Ser-244突变体所赋予的克拉维酸耐药性因第二个突变(第164位的精氨酸突变为丝氨酸)而逆转,该突变增强了对头孢他啶的活性。
Antimicrob Agents Chemother. 1994 May;38(5):1134-9. doi: 10.1128/AAC.38.5.1134.
7
TEM-121, a novel complex mutant of TEM-type beta-lactamase from Enterobacter aerogenes.TEM-121,一种来自产气肠杆菌的新型TEM型β-内酰胺酶复合突变体。
Antimicrob Agents Chemother. 2004 Dec;48(12):4528-31. doi: 10.1128/AAC.48.12.4528-4531.2004.
8
X-ray structure of the Asn276Asp variant of the Escherichia coli TEM-1 beta-lactamase: direct observation of electrostatic modulation in resistance to inactivation by clavulanic acid.大肠杆菌TEM-1 β-内酰胺酶Asn276Asp变体的X射线结构:直接观察对克拉维酸失活抗性中的静电调节
Biochemistry. 1999 Jul 27;38(30):9570-6. doi: 10.1021/bi990758z.
9
Understanding resistance to beta-lactams and beta-lactamase inhibitors in the SHV beta-lactamase: lessons from the mutagenesis of SER-130.了解SHVβ-内酰胺酶对β-内酰胺类和β-内酰胺酶抑制剂的耐药性:丝氨酸130诱变的启示
J Biol Chem. 2003 Dec 26;278(52):52724-9. doi: 10.1074/jbc.M306059200. Epub 2003 Oct 8.
10
Molecular epidemiology of the plasmid-encoded TEM-1 beta-lactamase in Scotland.苏格兰质粒编码的TEM-1β-内酰胺酶的分子流行病学
Epidemiol Infect. 1993 Feb;110(1):117-25. doi: 10.1017/s0950268800050743.

引用本文的文献

1
Tackling the Antibiotic Resistance Caused by Class A -Lactamases through the Use of -Lactamase Inhibitory Protein.通过使用β-内酰胺酶抑制蛋白来解决由 A 类β-内酰胺酶引起的抗生素耐药性。
Int J Mol Sci. 2018 Jul 30;19(8):2222. doi: 10.3390/ijms19082222.

本文引用的文献

1
The positive activator of cephamycin C and clavulanic acid production in Streptomyces clavuligerus is mistranslated in a bldA mutant.棒状链霉菌中头孢霉素C和克拉维酸生产的正激活剂在bldA突变体中翻译错误。
Microbiology (Reading). 2002 Mar;148(Pt 3):643-656. doi: 10.1099/00221287-148-3-643.
2
TEM-89 beta-lactamase produced by a Proteus mirabilis clinical isolate: new complex mutant (CMT 3) with mutations in both TEM-59 (IRT-17) and TEM-3.奇异变形杆菌临床分离株产生的TEM-89β-内酰胺酶:一种新型复合突变体(CMT 3),在TEM-59(IRT-17)和TEM-3中均有突变。
Antimicrob Agents Chemother. 2001 Dec;45(12):3591-4. doi: 10.1128/AAC.45.12.3591-3594.2001.
3
Binding properties of a peptide derived from beta-lactamase inhibitory protein.源自β-内酰胺酶抑制蛋白的一种肽的结合特性
Antimicrob Agents Chemother. 2001 Dec;45(12):3279-86. doi: 10.1128/AAC.45.12.3279-3286.2001.
4
Epidemiological survey of amoxicillin-clavulanate resistance and corresponding molecular mechanisms in Escherichia coli isolates in France: new genetic features of bla(TEM) genes.法国大肠杆菌分离株中阿莫西林-克拉维酸耐药性及其相应分子机制的流行病学调查:bla(TEM)基因的新遗传特征
Antimicrob Agents Chemother. 2000 Oct;44(10):2709-14. doi: 10.1128/AAC.44.10.2709-2714.2000.
5
TEM-72, a new extended-spectrum beta-lactamase detected in Proteus mirabilis and Morganella morganii in Italy.TEM-72,一种在意大利奇异变形杆菌和摩根摩根菌中检测到的新型超广谱β-内酰胺酶。
Antimicrob Agents Chemother. 2000 Sep;44(9):2537-9. doi: 10.1128/AAC.44.9.2537-2539.2000.
6
A novel complex mutant beta-lactamase, TEM-68, identified in a Klebsiella pneumoniae isolate from an outbreak of extended-spectrum beta-lactamase-producing Klebsiellae.在一株产超广谱β-内酰胺酶肺炎克雷伯菌暴发分离株中鉴定出一种新型复合突变β-内酰胺酶TEM-68。
Antimicrob Agents Chemother. 2000 Jun;44(6):1499-505. doi: 10.1128/AAC.44.6.1499-1505.2000.
7
Construction and characterization of mutants of the TEM-1 beta-lactamase containing amino acid substitutions associated with both extended-spectrum resistance and resistance to beta-lactamase inhibitors.构建并鉴定含有与超广谱耐药性和对β-内酰胺酶抑制剂耐药性相关氨基酸取代的TEM-1β-内酰胺酶突变体。
Antimicrob Agents Chemother. 1999 Aug;43(8):1881-7. doi: 10.1128/AAC.43.8.1881.
8
Molecular characterization of TEM-59 (IRT-17), a novel inhibitor-resistant TEM-derived beta-lactamase in a clinical isolate of Klebsiella oxytoca.产酸克雷伯菌临床分离株中新型耐抑制剂TEM衍生β-内酰胺酶TEM-59(IRT-17)的分子特征
Antimicrob Agents Chemother. 1999 Jul;43(7):1657-61. doi: 10.1128/AAC.43.7.1657.
9
Sequences of the genes for the TEM-20, TEM-21, TEM-22, and TEM-29 extended-spectrum beta-lactamases.TEM-20、TEM-21、TEM-22和TEM-29超广谱β-内酰胺酶的基因序列。
Antimicrob Agents Chemother. 1999 Apr;43(4):969-71. doi: 10.1128/AAC.43.4.969.
10
Identification of residues in beta-lactamase critical for binding beta-lactamase inhibitory protein.鉴定β-内酰胺酶中对结合β-内酰胺酶抑制蛋白至关重要的残基。
J Biol Chem. 1999 Mar 12;274(11):6963-71. doi: 10.1074/jbc.274.11.6963.